Get the Stockscreener App
18.71
0.27%
-0.05
After Hours:
18.6819
-0.0281
-0.15%
Avanos Medical Inc stock is currently priced at $18.71, with a 24-hour trading volume of 166.87K.
It has seen a -0.27% decreased in the last 24 hours and a -4.05% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $18.87 pivot point. If it approaches the $18.59 support level, significant changes may occur.
Previous Close:
$18.76
Open:
$18.61
24h Volume:
166.87K
Market Cap:
$864.48M
Revenue:
$705.70M
Net Income/Loss:
$-61.80M
P/E Ratio:
-15.72
EPS:
-1.19
Net Cash Flow:
$14.60M
1W Performance:
+0.00%
1M Performance:
-4.05%
6M Performance:
+2.46%
1Y Performance:
-39.61%
1D Range:
$18.55
$18.82
52W Range:
$17.23
$30.65
Avanos Medical Inc Stock (AVNS) Company Profile
Name
Avanos Medical Inc
Sector
Industry
Phone
678-425-9273
Address
5405 Windward Parkway, Suite 100 South, Alpharetta, GA
Avanos Medical Inc Stock (AVNS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-22-23 | Initiated | CL King | Buy |
| Aug-04-21 | Downgrade | Stephens | Overweight → Equal-Weight |
| Apr-13-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Nov-07-19 | Downgrade | Stifel | Buy → Hold |
| Nov-06-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Aug-21-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Avanos Medical Inc Stock (AVNS) Latest News
Three Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
Zacks Investment Research
Why Is Integra (IART) Down 4% Since Last Earnings Report?
Zacks Investment Research
Avanos (AVNS) Q4 Earnings Lag Estimates, Margins Contract
Zacks Investment Research
New Strong Sell Stocks for January 16th
Zacks Investment Research
New Strong Sell Stocks for January 12th
Zacks Investment Research
New Strong Sell Stocks for January 9th
Zacks Investment Research
Avanos Medical Inc Stock (AVNS) Financials Data
Avanos Medical Inc (AVNS) Revenue 2024
AVNS reported a revenue (TTM) of $705.70 million for the quarter ending December 31, 2023, a -2.28% decline year-over-year.
Avanos Medical Inc (AVNS) Net Income 2024
AVNS net income (TTM) was -$61.80 million for the quarter ending December 31, 2023, a -222.38% decrease year-over-year.
Avanos Medical Inc (AVNS) Cash Flow 2024
AVNS recorded a free cash flow (TTM) of $14.60 million for the quarter ending December 31, 2023, a -79.61% decrease year-over-year.
Avanos Medical Inc (AVNS) Earnings per Share 2024
AVNS earnings per share (TTM) was -$1.32 for the quarter ending December 31, 2023, a -224.53% decline year-over-year.
About Avanos Medical Inc
Avanos Medical, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management. Its products include post-operative pain management solutions, minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. This segment sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and other brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
0.19%
0.61%
Cap:
|
Volume (24h):